Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop.

[1]  C. Selmi,et al.  Criteria for environmentally associated autoimmune diseases. , 2012, Journal of autoimmunity.

[2]  S. Gay,et al.  Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases? , 2012, Autoimmunity reviews.

[3]  Ana Lleo,et al.  Geoepidemiology, gender and autoimmune disease. , 2012, Autoimmunity reviews.

[4]  A. Sawalha,et al.  Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus. , 2012, Journal of autoimmunity.

[5]  K. Pollard.  Gender differences in autoimmunity associated with exposure to environmental factors. , 2012, Journal of autoimmunity.

[6]  D. Ye,et al.  The therapeutic potential of the targeted autoreactive B lymphocytes by rituximab in SLE. , 2012, Autoimmunity reviews.

[7]  M. Klinker,et al.  Multiple Mechanisms of Immune Suppression by B Lymphocytes , 2012, Molecular medicine.

[8]  G. Hughes,et al.  The spectrum of ASIA: ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants’ , 2012, Lupus.

[9]  K. Mills,et al.  TLR-dependent T cell activation in autoimmunity , 2011, Nature Reviews Immunology.

[10]  A. Papini,et al.  Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis , 2011, Archives of medical science : AMS.

[11]  B. Hemmer,et al.  The increasing incidence and prevalence of female multiple sclerosis--a critical analysis of potential environmental factors. , 2011, Autoimmunity reviews.

[12]  A. Baccarelli,et al.  The epigenetics of autoimmunity , 2011, Cellular and Molecular Immunology.

[13]  R. Scearce,et al.  Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis. , 2011, Arthritis and rheumatism.

[14]  K. Moudgil,et al.  Nicotine-induced differential modulation of autoimmune arthritis in the Lewis rat involves changes in interleukin-17 and anti-cyclic citrullinated peptide antibodies. , 2011, Arthritis and rheumatism.

[15]  Y. Shoenfeld,et al.  'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. , 2011, Journal of autoimmunity.

[16]  P. Meroni.  Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): old truths and a new syndrome? , 2011, Journal of autoimmunity.

[17]  F. Gilliland,et al.  Genetic variation in the glutathione synthesis pathway, air pollution, and children's lung function growth. , 2011, American journal of respiratory and critical care medicine.

[18]  J. Buckner.  Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases , 2010, Nature Reviews Immunology.

[19]  Ying C. Song,et al.  Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes. , 2010, Journal of autoimmunity.

[20]  John R. Ledford,et al.  Early Immunological Response to German Cockroach Frass Exposure Induces a Th2/Th17 Environment , 2010, Journal of Innate Immunity.

[21]  A. Tzioufas,et al.  Autoimmune response and target autoantigens in Sjogren’s syndrome , 2010, European journal of clinical investigation.

[22]  M. Crow,et al.  Activation of the type I interferon pathway in primary Sjogren's syndrome. , 2010, Journal of autoimmunity.

[23]  C. Langefeld,et al.  Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus. , 2010, Arthritis and rheumatism.

[24]  T. Macdonald,et al.  IL‐23/IL‐17 axis in IBD , 2010, Inflammatory bowel diseases.

[25]  J. Fechner,et al.  An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells , 2010, The Journal of Immunology.

[26]  H. Weiner,et al.  Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell–like and Foxp3+ regulatory T cells , 2010, Nature Immunology.

[27]  A. Barchowsky,et al.  Multiple protein kinase pathways mediate amplified IL-6 release by human lung fibroblasts co-exposed to nickel and TLR-2 agonist, MALP-2. , 2010, Toxicology and applied pharmacology.

[28]  G. Gores,et al.  Biliary apotopes and anti‐mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis , 2010, Hepatology.

[29]  Fabio Macciardi,et al.  Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis , 2010, Nature Genetics.

[30]  G. Tobón,et al.  The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis. , 2010, Journal of autoimmunity.

[31]  D. Liu,et al.  Clinical advances in hypomethylating agents targeting epigenetic pathways. , 2010, Current cancer drug targets.

[32]  A. Skol,et al.  Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus , 2010, Arthritis research & therapy.

[33]  H. Weiner,et al.  The Aryl hydrocarbon Receptor (AhR) interacts with c-Maf to promote the differentiation of IL-27-induced regulatory type 1 (TR1) cells , 2010, Nature Immunology.

[34]  J. Bassaganya-Riera,et al.  The Role of T cell PPAR γ in mice with experimental inflammatory bowel disease , 2010, BMC Gastroenterology.

[35]  V. Poindron,et al.  Peripheral B cell abnormalities in patients with systemic lupus erythematosus in quiescent phase: decreased memory B cells and membrane CD19 expression. , 2010, Journal of autoimmunity.

[36]  Chen Dong,et al.  Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. , 2010, Immunity.

[37]  Jeff E. Mold,et al.  Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of TH17 to Regulatory T Cells in HIV Disease , 2010, Science Translational Medicine.

[38]  Jing Cui,et al.  Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci , 2010, Nature Genetics.

[39]  Pietro Invernizzi,et al.  Geoepidemiology of autoimmune liver diseases. , 2010, Journal of autoimmunity.

[40]  D. Fox,et al.  Targeting IL-17 and Th17 cells in rheumatoid arthritis. , 2010, Rheumatic diseases clinics of North America.

[41]  Lei Yu,et al.  Association of TLR9 gene polymorphisms with lupus nephritis in a Chinese Han population. , 2010, Clinical and experimental rheumatology.

[42]  Y. Shoenfeld,et al.  Defining and analyzing geoepidemiology and human autoimmunity. , 2010, Journal of autoimmunity.

[43]  K. Hemminki,et al.  The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution. , 2010, Journal of autoimmunity.

[44]  G. Perdew,et al.  Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[45]  Annette Lee,et al.  Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus , 2010, Nature Genetics.

[46]  Vinod Chandran,et al.  Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. , 2010, Journal of autoimmunity.

[47]  Sanjeev Kumar,et al.  Protein–DNA Complex Is the Exclusive Malaria Parasite Component That Activates Dendritic Cells and Triggers Innate Immune Responses , 2010, The Journal of Immunology.

[48]  Y. Shoenfeld,et al.  Challenges for the Autoimmunologist , 2010, Clinical reviews in allergy & immunology.

[49]  D. Sherr,et al.  Disruption of human plasma cell differentiation by an environmental polycyclic aromatic hydrocarbon: a mechanistic immunotoxicological study , 2010, Environmental health : a global access science source.

[50]  A. Taylor-Robinson,et al.  Tomatine Adjuvantation of Protective Immunity to a Major Pre-erythrocytic Vaccine Candidate of Malaria is Mediated via CD8+ T Cell Release of IFN-γ , 2010, Journal of biomedicine & biotechnology.

[51]  L. Mouthon,et al.  Geoepidemiology of systemic sclerosis. , 2010, Autoimmunity reviews.

[52]  B. Segal.  Th17 cells in autoimmune demyelinating disease , 2010, Seminars in Immunopathology.

[53]  Delong Liu,et al.  Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents , 2010, Journal of hematology & oncology.

[54]  P. Laird.  Principles and challenges of genome-wide DNA methylation analysis , 2010, Nature Reviews Genetics.

[55]  P. Sham,et al.  Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus , 2010, PLoS genetics.

[56]  D. Scott‐Algara,et al.  Changes to the Natural Killer Cell Repertoire after Therapeutic Hepatitis B DNA Vaccination , 2010, PloS one.

[57]  D. Metzger,et al.  Emerging Roles of T Helper Subsets in the Pathogenesis of Asthma , 2010, Immunological investigations.

[58]  M. Feldmann,et al.  Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis , 2010, Immunological reviews.

[59]  T. Tedder,et al.  B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer , 2010, Annals of the New York Academy of Sciences.

[60]  N. Kerkvliet,et al.  Dioxin and immune regulation , 2010, Annals of the New York Academy of Sciences.

[61]  R. Gay,et al.  DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. , 2009, Arthritis and rheumatism.

[62]  D. Baker,et al.  Ustekinumab: Lessons Learned from Targeting Interleukin‐12/23p40 in Immune‐Mediated Diseases , 2009, Annals of the New York Academy of Sciences.

[63]  Arnaud M. Didierlaurent,et al.  AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity1 , 2009, The Journal of Immunology.

[64]  Glinda S Cooper,et al.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. , 2009, Journal of autoimmunity.

[65]  Ying Wang,et al.  Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus , 2009, Nature Genetics.

[66]  P. Lipsky,et al.  B cells in autoimmunity , 2009, Arthritis research & therapy.

[67]  Javier Martín,et al.  Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus. , 2009, Human molecular genetics.

[68]  A. Papini.  The use of post‐translationally modified peptides for detection of biomarkers of immune‐mediated diseases , 2009, Journal of peptide science : an official publication of the European Peptide Society.

[69]  D. Armant,et al.  Epigenetics: Definition, Mechanisms and Clinical Perspective , 2009, Seminars in reproductive medicine.

[70]  M. Veldhoen,et al.  Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. , 2009, Immunity.

[71]  Sean L. Evans,et al.  Mercury Induces an Unopposed Inflammatory Response in Human Peripheral Blood Mononuclear Cells in Vitro , 2009, Environmental health perspectives.

[72]  B. Baban,et al.  IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells1 , 2009, The Journal of Immunology.

[73]  J. Brayer,et al.  TLR5 ligation by flagellin converts tolerogenic dendritic cells into activating antigen-presenting cells that preferentially induce T-helper 1 responses. , 2009, Immunology letters.

[74]  D. C. Graham,et al.  Genome-wide association studies in systemic lupus erythematosus: a perspective , 2009 .

[75]  N. Kerkvliet,et al.  Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes. , 2009, Immunotherapy.

[76]  C. Mohan,et al.  Three checkpoints in lupus development: central tolerance in adaptive immunity, peripheral amplification by innate immunity and end-organ inflammation , 2009, Genes and Immunity.

[77]  E. Maraskovsky,et al.  Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant , 2009, Immunology and cell biology.

[78]  F. Nestle,et al.  The IL-23/Th17 axis in the immunopathogenesis of psoriasis. , 2009, The Journal of investigative dermatology.

[79]  J. Kanno,et al.  Neonatal Exposure to Low-Dose 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Causes Autoimmunity Due to the Disruption of T Cell Tolerance1 , 2009, The Journal of Immunology.

[80]  D. Clayton,et al.  Genome-wide association study and meta-analysis finds over 40 loci affect risk of type 1 diabetes , 2009, Nature Genetics.

[81]  B. Homey,et al.  Clinic and pathophysiology of photosensitivity in lupus erythematosus. , 2009, Autoimmunity reviews.

[82]  H. Cedar,et al.  Linking DNA methylation and histone modification: patterns and paradigms , 2009, Nature Reviews Genetics.

[83]  Gisen Kim,et al.  Retinoic acid can directly promote TGF-beta-mediated Foxp3(+) Treg cell conversion of naive T cells. , 2009, Immunity.

[84]  I. Dimier-Poisson,et al.  Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant. , 2009, Vaccine.

[85]  William Bourguet,et al.  Activation of RXR–PPAR heterodimers by organotin environmental endocrine disruptors , 2009, EMBO reports.

[86]  Antonella Zanobetti,et al.  Rapid DNA methylation changes after exposure to traffic particles. , 2009, American journal of respiratory and critical care medicine.

[87]  G. Hannon,et al.  Ezh2 Orchestrates Gene Expression for the Stepwise Differentiation of Tissue-Specific Stem Cells , 2009, Cell.

[88]  Hongxiang Sun,et al.  Advances in saponin-based adjuvants. , 2009, Vaccine.

[89]  I. Mackay,et al.  Apotopes and the biliary specificity of primary biliary cirrhosis , 2009, Hepatology.

[90]  H. Weiner,et al.  Environmental control of Th17 differentiation , 2009, European journal of immunology.

[91]  F. Tang,et al.  Effects of insulin and glucose on cellular metabolic fluxes in homocysteine transsulfuration, remethylation, S-adenosylmethionine synthesis, and global deoxyribonucleic acid methylation. , 2009, The Journal of clinical endocrinology and metabolism.

[92]  I. Mackay,et al.  B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis. , 2009, Gastroenterology.

[93]  N. Kerkvliet.  AHR-mediated immunomodulation: the role of altered gene transcription. , 2009, Biochemical pharmacology.

[94]  E. Lien,et al.  The role of Toll-like receptor pathways in the mechanism of type 1 diabetes. , 2009, Current molecular medicine.

[95]  E. Zimlichman,et al.  The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. , 2008, Journal of autoimmunity.

[96]  Sudhir Gupta.  Immune Homeostasis: Regulatory T Cells (Treg) and Molecules , 2008, Journal of Clinical Immunology.

[97]  F. Matsumura,et al.  Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. , 2008, Biochemical and biophysical research communications.

[98]  V. Kuchroo,et al.  Interplay Between Effector Th17 and Regulatory T Cells , 2008, Journal of Clinical Immunology.

[99]  T. Chatila.  Molecular Mechanisms of Regulatory T Cell Development , 2008, Journal of Clinical Immunology.

[100]  R. Read,et al.  Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. , 2008, Arthritis and rheumatism.

[101]  E. Hauben,et al.  Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells. , 2008, Blood.

[102]  N. Kerkvliet,et al.  Functional Characterization and Gene Expression Analysis of CD4+CD25+ Regulatory T Cells Generated in Mice Treated with 2,3,7,8-Tetrachlorodibenzo-p-Dioxin1 , 2008, The Journal of Immunology.

[103]  T. Tedder,et al.  Regulatory B cells as inhibitors of immune responses and inflammation , 2008, Immunological reviews.

[104]  Y. Nakanuma,et al.  Activation of ATM signaling pathway is involved in oxidative stress-induced expression of mito-inhibitory p21WAF1/Cip1 in chronic non-suppurative destructive cholangitis in primary biliary cirrhosis: an immunohistochemical study. , 2008, Journal of autoimmunity.

[105]  Y. Fujii‐Kuriyama,et al.  Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells , 2008, Proceedings of the National Academy of Sciences.

[106]  L. Steinman,et al.  The aryl hydrocarbon receptor: a regulator of Th17 and Treg cell development in disease , 2008, Cell Research.

[107]  H. Weiner,et al.  Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor , 2008, Nature.

[108]  Q. Lu,et al.  DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients. , 2008, Autoimmunity reviews.

[109]  J. Buer,et al.  The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins , 2008, Nature.

[110]  S. Diebold,et al.  Recognition of viral single-stranded RNA by Toll-like receptors. , 2008, Advanced drug delivery reviews.

[111]  G. Leroux-Roels,et al.  Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. , 2008, Vaccine.

[112]  C. Liu,et al.  Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice. , 2008, The Journal of clinical investigation.

[113]  S. Beissert,et al.  Phenotypic and Functional Characterization of Ultraviolet Radiation-Induced Regulatory T Cells1 , 2008, The Journal of Immunology.

[114]  E. Jacobson,et al.  The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. , 2008, Journal of autoimmunity.

[115]  A. Morita,et al.  Narrowband ultraviolet B radiation suppresses contact hypersensitivity , 2008, Photodermatology, photoimmunology & photomedicine.

[116]  M. Shlomchik.  Sites and stages of autoreactive B cell activation and regulation. , 2008, Immunity.

[117]  N. Rose.  The Adjuvant Effect in Infection and Autoimmunity , 2008, Clinical reviews in allergy & immunology.

[118]  I. Mackay.  Autoimmunity since the 1957 clonal selection theory: a little acorn to a large oak , 2008, Immunology and cell biology.

[119]  N. Kerkvliet,et al.  2,3,7,8-Tetrachlorodibenzo-p-dioxin Alters the Differentiation of Alloreactive CD8+ T Cells Toward a Regulatory T Cell Phenotype by a Mechanism that is Dependent on Aryl Hydrocarbon Receptor in CD4+ T Cells , 2008, Journal of immunotoxicology.

[120]  Christophe Benoist,et al.  Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. , 2007, Immunity.

[121]  M. Vilardell‐Tarrés,et al.  DNA Methylation and Systemic Lupus Erythematosus , 2007, Annals of the New York Academy of Sciences.

[122]  R. Jirtle,et al.  Environmental epigenomics and disease susceptibility , 2007, Nature Reviews Genetics.

[123]  Raquel Hontecillas,et al.  Peroxisome Proliferator-Activated Receptor γ Is Required for Regulatory CD4+ T Cell-Mediated Protection against Colitis , 2007, The Journal of Immunology.

[124]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[125]  G. Harauz,et al.  A Tale of Two Citrullines—Structural and Functional Aspects of Myelin Basic Protein Deimination in Health and Disease , 2007, Neurochemical Research.

[126]  F. Mastronardi,et al.  The Role of Citrullinated Proteins Suggests a Novel Mechanism in the Pathogenesis of Multiple Sclerosis , 2006, Neurochemical Research.

[127]  P. Hultman,et al.  Organic mercury compounds and autoimmunity. , 2005, Autoimmunity reviews.

[128]  Q. Lu,et al.  Demethylation of the Same Promoter Sequence Increases CD70 Expression in Lupus T Cells and T Cells Treated with Lupus-Inducing Drugs1 , 2005, The Journal of Immunology.

[129]  S. Hanash,et al.  Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. , 2004, Arthritis and rheumatism.

[130]  N. LaRusso,et al.  Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. , 2001, The Journal of clinical investigation.

[131]  R. Rappuoli,et al.  Mutants of Escherichia coli Heat-Labile Toxin Act as Effective Mucosal Adjuvants for Nasal Delivery of an Acellular Pertussis Vaccine: Differential Effects of the Nontoxic AB Complex and Enzyme Activity on Th1 and Th2 Cells , 1999, Infection and Immunity.

[132]  E. Tan,et al.  The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties. , 1997, Journal of immunology.

[133]  Hui Zhang,et al.  Chronic alcohol consumption decreases the percentage and number of NK cells in the peripheral lymph nodes and exacerbates B16BL6 melanoma metastasis into the draining lymph nodes. , 2011, Cellular immunology.

[134]  T. Tedder,et al.  Identifying regulatory B cells (B10 cells) that produce IL-10 in mice. , 2011, Methods in molecular biology.

[135]  C. Selmi,et al.  Experimental evidence on the immunopathogenesis of primary biliary cirrhosis , 2010, Cellular and Molecular Immunology.

[136]  M. Gershwin,et al.  Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes , 2010, Journal of Gastroenterology.

[137]  Fritz Melchers,et al.  Checkpoints in lymphocyte development and autoimmune disease , 2010, Nature Immunology.

[138]  Jia Newcombe,et al.  Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. , 2008, The American journal of pathology.